NEXI
Price:
$0.35
Market Cap:
$488.13K
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted...[Read more]
Industry
Biotechnology
IPO Date
2021-02-12
Stock Exchange
NASDAQ
Ticker
NEXI
According to NexImmune, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of NexImmune, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NEXI's Dividend Yield was at its highest in in the December 2019 quarter at 0%. The Dividend Yield was at its lowest in in the December 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of NexImmune, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
The current Dividend Yield of NexImmune, Inc. (NEXI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
NexImmune, Inc.’s Dividend Yield is less than ZyVersa Therapeutics, Inc. (0%), less than Palisade Bio, Inc. (0%), less than Unicycive Therapeutics, Inc. (0%), less than Apexigen, Inc. (0%), less than Immix Biopharma, Inc. (0%), less than TransCode Therapeutics, Inc. (0%), less than Landos Biopharma, Inc. (0%), less than Oncorus, Inc. (115.63%), less than Xenetic Biosciences, Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%), less than Virios Therapeutics, Inc. (0%), less than Zura Bio Limited (0%), less than Navidea Biopharmaceuticals, Inc. (0%), less than CNS Pharmaceuticals, Inc. (0%), less than Sonnet BioTherapeutics Holdings, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Terns Pharmaceuticals, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than Inozyme Pharma, Inc. (0%), less than HOOKIPA Pharma Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $2.65M | |
0% | $3.24M | |
0% | $55.01M | |
0% | $9.57M | |
0% | $49.14M | |
0% | $6.64M | |
0% | $71.68M | |
115.63% | $0 | |
0% | $6.33M | |
0% | $941.00 | |
0% | $206.50K | |
0% | $178.25M | |
0% | $100.08K | |
0% | $7.15M | |
0% | $2.50M | |
0% | $575.61M | |
0% | $491.80M | |
0% | $78.19M | |
0% | $180.51M | |
0% | $20.76M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NexImmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NexImmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is NexImmune, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for NexImmune, Inc. (NEXI)?
What is the highest Dividend Yield for NexImmune, Inc. (NEXI)?
What is the 3-year average Dividend Yield for NexImmune, Inc. (NEXI)?
What is the 5-year average Dividend Yield for NexImmune, Inc. (NEXI)?
How does the current Dividend Yield for NexImmune, Inc. (NEXI) compare to its historical average?